2025 Vol.43, N°1 - Table of contents
January 2025
In Memoriam
CER18565
2025,43,1
Pg. 0000
Free to view
In Memoriam of Salvatore De Vita
L. Quartuccio, S. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/nka61o
L. Quartuccio, S. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/nka61o
Editorial
CER18096
2025,43,1
Pg. 0001-0003
Free to view
Fibromyalgia: a satellite gliopathy?
F. Mercado, A. Almanza, L.-A. Martínez-Martínez, M. Martínez-Lavín
DOI: https://doi.org/10.55563/clinexprheumatol/yehag6
F. Mercado, A. Almanza, L.-A. Martínez-Martínez, M. Martínez-Lavín
DOI: https://doi.org/10.55563/clinexprheumatol/yehag6
One year in review
CER18548
2025,43,1
Pg. 0004-0013
Free to view
Clinical aspects of psoriatic arthritis: one year in review 2024
L. Esti, F. Fattorini, C. Cigolini, S. Gentileschi, R. Terenzi, L. Carli
DOI: https://doi.org/10.55563/clinexprheumatol/7gug1a
L. Esti, F. Fattorini, C. Cigolini, S. Gentileschi, R. Terenzi, L. Carli
DOI: https://doi.org/10.55563/clinexprheumatol/7gug1a
Rapid paper
CER18050
2025,43,1
Pg. 0014-0020
Tumour necrosis factor-like weak inducer of apoptosis participates in the development of cutaneous fibrosis in an experimental systemic sclerosis model
M. Lu, X. Wang, S. Kang, H. Gu, Y. Tian, F. Liu, Y. Dong, X. Liu, Y. Xia
DOI: https://doi.org/10.55563/clinexprheumatol/adk254
M. Lu, X. Wang, S. Kang, H. Gu, Y. Tian, F. Liu, Y. Dong, X. Liu, Y. Xia
DOI: https://doi.org/10.55563/clinexprheumatol/adk254
Environmental Rheumatology
CER18056
2025,43,1
Pg. 0021-0027
Free to view
Stressful life events are associated with the diagnosis of systemic autoimmune rheumatic diseases among adults
I. Bauer Ventura, M.E. Goldberg, A. Schiffenbauer, M. Shi, R. Volochayev, S.H. Jackson, A. Jansen, N. Bayat, P. Noroozi Farhadi, C.G. Parks, C.R. Weinberg, A. Picardi, F.W. Miller, L.G. Rider
DOI: https://doi.org/10.55563/clinexprheumatol/slj5sf
I. Bauer Ventura, M.E. Goldberg, A. Schiffenbauer, M. Shi, R. Volochayev, S.H. Jackson, A. Jansen, N. Bayat, P. Noroozi Farhadi, C.G. Parks, C.R. Weinberg, A. Picardi, F.W. Miller, L.G. Rider
DOI: https://doi.org/10.55563/clinexprheumatol/slj5sf
Full Papers
CER17729
2025,43,1
Pg. 0028-0033
A new instrument for the screening of psoriatic arthritis among psoriatic patients
G. De Marco, A. Marchesoni, M. Manara, P. Gisondi, L. Idolazzi, R. Ramonda, S. Piaserico, A. Cauli, M.A. Cimmino, V. Tomatis, C. Salvarani, R. Scrivo, A. Zanetti, G. Carrara, C.A. Scirè, A. Cattaneo
DOI: https://doi.org/10.55563/clinexprheumatol/ug6vti
G. De Marco, A. Marchesoni, M. Manara, P. Gisondi, L. Idolazzi, R. Ramonda, S. Piaserico, A. Cauli, M.A. Cimmino, V. Tomatis, C. Salvarani, R. Scrivo, A. Zanetti, G. Carrara, C.A. Scirè, A. Cattaneo
DOI: https://doi.org/10.55563/clinexprheumatol/ug6vti
CER17768
2025,43,1
Pg. 0034-0040
Interleukin-18 binding protein regulates mast cell activation and mast cell induced osteoclastogenesis of rheumatoid arthritis
H.K. Min, J.-Y. Lee, S.-H. Lee, H.-R. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/zf6zct
H.K. Min, J.-Y. Lee, S.-H. Lee, H.-R. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/zf6zct
CER17748
2025,43,1
Pg. 0041-0047
Free to view
Potential difficult-to-treat psoriatic arthritis real-world prevalence and contributing factors
G. Alp, M. Kara, H. Cinakli
DOI: https://doi.org/10.55563/clinexprheumatol/pqpzef
G. Alp, M. Kara, H. Cinakli
DOI: https://doi.org/10.55563/clinexprheumatol/pqpzef
CER17651
2025,43,1
Pg. 0048-0052
Free to view
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment
M. Piga, L. Quartuccio, F. Atzeni, A. Doria, G. Emmi, F. Franceschini, M. Gerosa, M. Mosca, P. Pasqualetti, G.D. Sebastiani, F. Conti, M. Govoni
DOI: https://doi.org/10.55563/clinexprheumatol/25a2qk
M. Piga, L. Quartuccio, F. Atzeni, A. Doria, G. Emmi, F. Franceschini, M. Gerosa, M. Mosca, P. Pasqualetti, G.D. Sebastiani, F. Conti, M. Govoni
DOI: https://doi.org/10.55563/clinexprheumatol/25a2qk
CER17655
2025,43,1
Pg. 0053-0061
Free to view
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment
L. Quartuccio, M. Piga, F. Atzeni, M. Callori, A. Doria, G. Emmi, F. Franceschini, M. Gerosa, M. Mosca, P. Pasqualetti, R. Pelissero, G.D. Sebastiani, F. Conti, M. Govoni
DOI: https://doi.org/10.55563/clinexprheumatol/clx4p7
L. Quartuccio, M. Piga, F. Atzeni, M. Callori, A. Doria, G. Emmi, F. Franceschini, M. Gerosa, M. Mosca, P. Pasqualetti, R. Pelissero, G.D. Sebastiani, F. Conti, M. Govoni
DOI: https://doi.org/10.55563/clinexprheumatol/clx4p7
CER17847
2025,43,1
Pg. 0062-0069
Free to view
Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis
J. Fournier, B. Boussat, B. Dervaux, P. Gaudin, X. Romand
DOI: https://doi.org/10.55563/clinexprheumatol/3f60yv
J. Fournier, B. Boussat, B. Dervaux, P. Gaudin, X. Romand
DOI: https://doi.org/10.55563/clinexprheumatol/3f60yv
CER17899
2025,43,1
Pg. 0070-0078
Mapping in healthy subjects different body areas for dermal thickness and skin hardness by high frequency ultrasound and durometry
M. Cutolo, E. Hysa, N. Berghen, T. Du Four, A. Cere, K. Wyckstandt, E. Gotelli, V. Smith
DOI: https://doi.org/10.55563/clinexprheumatol/s12eoy
M. Cutolo, E. Hysa, N. Berghen, T. Du Four, A. Cere, K. Wyckstandt, E. Gotelli, V. Smith
DOI: https://doi.org/10.55563/clinexprheumatol/s12eoy
CER17564
2025,43,1
Pg. 0079-0086
Free to view
Suppressing anti-citrullinated protein antibody-induced osteoclastogenesis in rheumatoid arthritis using anti-CD64 and PAD-2 inhibitors
H.K. Min, J.-Y. Lee, S.-H. Lee, J.H. Ju, H.-R. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/d9iizz
H.K. Min, J.-Y. Lee, S.-H. Lee, J.H. Ju, H.-R. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/d9iizz
CER17488
2025,43,1
Pg. 0087-0095
Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism
O. Hagege, P. Brevet, B. Gerard, E. Duhamel, S.-D. Mihailescu, D. Alcaix, A.-J. Weber, C. Marcelli, J. Grosjean, R. Varin, T. Lequerré, O. Vittecoq
DOI: https://doi.org/10.55563/clinexprheumatol/6cxcaq
O. Hagege, P. Brevet, B. Gerard, E. Duhamel, S.-D. Mihailescu, D. Alcaix, A.-J. Weber, C. Marcelli, J. Grosjean, R. Varin, T. Lequerré, O. Vittecoq
DOI: https://doi.org/10.55563/clinexprheumatol/6cxcaq
CER17587
2025,43,1
Pg. 0096-0104
Positivity of antiphosphatidylserine/prothrombin antibodies identifies a subgroup of more severe antiphospholipid syndrome patients
A. Delarue, L. Darnige, A.F. Guedon, L. Khider, A. Philippe, A. Michon, J. Pouchot, A. Karras, L. Mauge, O. Sanchez, E. Messas, T. Mirault, M.-A. Dragon-Durey
DOI: https://doi.org/10.55563/clinexprheumatol/gna7r1
A. Delarue, L. Darnige, A.F. Guedon, L. Khider, A. Philippe, A. Michon, J. Pouchot, A. Karras, L. Mauge, O. Sanchez, E. Messas, T. Mirault, M.-A. Dragon-Durey
DOI: https://doi.org/10.55563/clinexprheumatol/gna7r1
CER17815
2025,43,1
Pg. 0105-0111
Th1/Th2 associated transcription factors and cytokines in pregnancies with systemic lupus erythematosus
S. Zhang, X. Han, W. Liu, G. Yin, Y. Jiang, J. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/rmp2pl
S. Zhang, X. Han, W. Liu, G. Yin, Y. Jiang, J. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/rmp2pl
CER17772
2025,43,1
Pg. 0112-0118
Free to view
A pilot trial of integrating the Patient-Reported Outcome Measurement Information System (PROMIS®) into rheumatology care
R. Gedert, D. Ochocki, N. Kortam, S. Huang, V. Nagaraja, K. Chakrabarti, J. Ford, M. Garber, J. Lee, V. Ognenovski, D. Roofeh, D. Cella, D. Khanna
DOI: https://doi.org/10.55563/clinexprheumatol/fp914f
R. Gedert, D. Ochocki, N. Kortam, S. Huang, V. Nagaraja, K. Chakrabarti, J. Ford, M. Garber, J. Lee, V. Ognenovski, D. Roofeh, D. Cella, D. Khanna
DOI: https://doi.org/10.55563/clinexprheumatol/fp914f
Reviews
CER17447
2025,43,1
Pg. 0119-0125
Free to view
Potential of phosphodiesterase 4B inhibitors in the treatment of interstitial lung disease associated with autoimmune diseases
F.V. Castelino, A. Adegunsoye
DOI: https://doi.org/10.55563/clinexprheumatol/yg6rck
F.V. Castelino, A. Adegunsoye
DOI: https://doi.org/10.55563/clinexprheumatol/yg6rck
CER17649
2025,43,1
Pg. 0126-0134
Free to view
Effect of collagen supplementation on knee osteoarthritis: an updated systematic review and meta-analysis of randomised controlled trials
M. Simental-Mendía, D. Ortega-Mata, C.A. Acosta-Olivo, L.E. Simental-Mendía, V.M. Peña-Martínez, F. Vilchez-Cavazos
DOI: https://doi.org/10.55563/clinexprheumatol/kflfr5
M. Simental-Mendía, D. Ortega-Mata, C.A. Acosta-Olivo, L.E. Simental-Mendía, V.M. Peña-Martínez, F. Vilchez-Cavazos
DOI: https://doi.org/10.55563/clinexprheumatol/kflfr5
CER17756
2025,43,1
Pg. 0135-0144
Free to view
The association between rheumatoid arthritis and left ventricular diastolic dysfunction: pathogenesis, predictors and managements
Y. Qian, B. Zhang, F. Nian
DOI: https://doi.org/10.55563/clinexprheumatol/kmmkj7
Y. Qian, B. Zhang, F. Nian
DOI: https://doi.org/10.55563/clinexprheumatol/kmmkj7
Paediatric Rheumatology
CER17617
2025,43,1
Pg. 0145-0150
Choroidal vascularity analysis in patients with juvenile idiopathic arthritis without acute uveitis
B. Iaccheri, N. De Santi, A. Cerquaglia, F. Della Lena, E. Bianchi, V. Gerli, D. Fruttini, J. Chhablani, C. Cagini, T. Fiore
DOI: https://doi.org/10.55563/clinexprheumatol/nddba1
B. Iaccheri, N. De Santi, A. Cerquaglia, F. Della Lena, E. Bianchi, V. Gerli, D. Fruttini, J. Chhablani, C. Cagini, T. Fiore
DOI: https://doi.org/10.55563/clinexprheumatol/nddba1
CER17497
2025,43,1
Pg. 0151-0159
Serum hepcidin evaluation as a promising biomarker in juvenile idiopathic arthritis
R. Troiani, S. La Bella, M. Muselli, M. D'egidio, G. Sassano, A. Di Ludovico, G. Di Donato, F. Lauriola, E. Altobelli, F. Chiarelli, L. Breda
DOI: https://doi.org/10.55563/clinexprheumatol/a51j2e
R. Troiani, S. La Bella, M. Muselli, M. D'egidio, G. Sassano, A. Di Ludovico, G. Di Donato, F. Lauriola, E. Altobelli, F. Chiarelli, L. Breda
DOI: https://doi.org/10.55563/clinexprheumatol/a51j2e
Letters to the Editor
CER17671
2025,43,1
Pg. 0160-0161
Free to view
Sarcoidosis and COVID-19: a research letter unveiling our insights
H.A. Krzepkowski, A.J. Białas, W.J. Piotrowski
DOI: https://doi.org/10.55563/clinexprheumatol/965ncg
H.A. Krzepkowski, A.J. Białas, W.J. Piotrowski
DOI: https://doi.org/10.55563/clinexprheumatol/965ncg
CER17922
2025,43,1
Pg. 0162-0163
Free to view
Low back pain in a child: a rare case of intramedullary schwannoma initially resembling juvenile spondyloarthritis
L. Giudice, G. Guida, S. Costi, A. Marino, C.B. Chighizola, R.F. Caporali
DOI: https://doi.org/10.55563/clinexprheumatol/5rh13q
L. Giudice, G. Guida, S. Costi, A. Marino, C.B. Chighizola, R.F. Caporali
DOI: https://doi.org/10.55563/clinexprheumatol/5rh13q
CER18249
2025,43,1
Pg. 0164
Free to view
Comment on: Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus
V. Moreno-Torres, R. Castejón Díaz
DOI: https://doi.org/10.55563/clinexprheumatol/6ots69
V. Moreno-Torres, R. Castejón Díaz
DOI: https://doi.org/10.55563/clinexprheumatol/6ots69
CER18303
2025,43,1
Pg. 0165
Free to view
Reply to comment on: Red blood cell distribution in systemic lupus erythematosus and other inflammatory diseases
I. Ferraz-Amaro, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/4tez44
I. Ferraz-Amaro, M.Á. González-Gay
DOI: https://doi.org/10.55563/clinexprheumatol/4tez44